NASDAQ:SNDX

Syndax Pharmaceuticals Inc [NASDAQ: SNDX] slipped around -1.52 points on Wednesday, while shares priced at $19.71 at the close of the session, down -7.16%. The company report on January 5, 2024 at 4:05 PM that Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).